BLAISE AGUIRRE, MD - Corporate Board Profile

UNITED STATES ANTIMONY CORP

Filing Date	Source Excerpt
2020-11-30	Blaise Aguirre, MD. Dr. Aguirre, who joined the Board in August 2019, is an Assistant Professor of Psychiatry at Harvard Medical School, and is the founding Medical Director of 3East at McLean Hospital in Belmont, Massachusetts. In 2011, he was elected to the Board of Directors at Investors Capital Holdings, Ltd, and remained on the Board until it was sold to RCS Capital Corporation. In addition, Dr. Aguirre sits on the boards of various privately held companies. He has developed and maintained relationships with institutional money managers, venture capitalists, angel investors and has developed expertise as a small cap stock analyst as a broker with series 7 and 63 securities licenses. He received his Medical Doctor’s degree in 1989 from the University of Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994.
2020-12-11	Blaise Aguirre, MD. Dr. Aguirre, who joined the Board in August 2019, is an Assistant Professor of Psychiatry at Harvard Medical School, and is the founding Medical Director of 3East at McLean Hospital in Belmont, Massachusetts. In 2011, he was elected to the Board of Directors at Investors Capital Holdings, Ltd, and remained on the Board until it was sold to RCS Capital Corporation. In addition, Dr. Aguirre sits on the boards of various privately held companies. He has developed and maintained relationships with institutional money managers, venture capitalists, angel investors and has developed expertise as a small cap stock analyst as a broker with series 7 and 63 securities licenses. He received his Medical Doctor’s degree in 1989 from the University of Witwatersrand, Johannesburg, South Africa, and performed his residency at Boston University School of Medicine from 1991 to 1994. The Audit Committee currently consists of Jeffrey D. Wright (Chairman), Craig W. Thomas and Blaise Aguirre. The following table sets forth certain information with respect to our directors who are named in this Proxy Statement. The ages of the directors are shown as of December 31, 2019. Blaise Aguirre, MD, Age 56, Director. Directors Compensation table shows $25,000 total fees.
2021-06-21	During 2020, Blaise Aguirre was a member of the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee. The directors will receive $25,000 or equivalent value in restricted Company common stock for 2020 and succeeding years until changed or circumstances otherwise permit a different award.
2022-06-09	Dr. Aguirre joined the Board in August 2019. He is an Assistant Professor of Psychiatry at Harvard Medical School. He served on the Audit Committee and Compensation Committee. He received $25,000 in stock awards for 2021.
2023-11-17	Blaise Aguirre, MD. Dr. Blaise Aguirre, who joined the Board in August 2019, is an Assistant Professor of Psychiatry at Harvard Medical School ... The Audit Committee consists of Gary C. Evans, Blaise Aguirre, and Michael McManus, each of whom is independent ... Our Compensation Committee is composed of the following directors, each of whom is independent: Blaise Aguirre, Lloyd Joseph Bardswich and Gary C. Evans. ... Our Nominating and Corporate Governance Committee is composed of the following directors, each of whom is independent: Michael McManus, Lloyd Joseph Bardswich and Blaise Aguirre. ... Following is a summary of fees, cash payments, stock awards, and other reimbursements to independent directors during the year ended December 31, 2022. Blaise Aguirre, MD $12,500 fees earned or paid in cash, $12,500 stock awards, total $25,000.